Evotec Receives Grants to Advance Tuberculosis Treatment
Go back to Evotec Receives Grants to Advance Tuberculosis Treatment| EATON VANCE OHIO MUNI INCOME T (NASDAQ: EVO) | Delayed: 2.64 +0.02 (0.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.62 | 52 Week High | $16.39 | |||
| Open | $2.60 | 52 Week Low | $13.22 | |||
| Day High | $2.68 | P/E | N/A | |||
| Day Low | $2.60 | EPS | $-1.61 | |||
| Volume | 16,427 | |||||

